WitrynaIn August 2024, Immunitas announced the completion of its $ 58 m Series B financing to bring its pipeline into the clinic and expand its single cell analysis platform for immune-oncology and other diseases. Immunitas is based in Waltham, USA. Here you can find more information about Immunitas. Initial investment year: 2024 Witryna5 paź 2024 · WALTHAM, Mass., Oct. 5, 2024 /PRNewswire/ -- Immunitas Therapeutics ("Immunitas"), a precision immunotherapy company committed to discovering and …
Immunitas Therapeutics Company Profile Management and …
Witryna12 lis 2024 · WALTHAM, MA, USA I November 11, 2024 I Immunitas Therapeutics ("Immunitas"), a clinical stage precision immunotherapy company committed to … Witryna15 gru 2024 · Immunitas: the human approach to oncology Position Summary Immunitas is seeking a motivated, enthusiastic scientist with experience in molecular biology. The successful candidate will join the Protein Science team and will be primarily responsible for generating DNA constructs to make proteins and cell lines in support … chilli thomas pics
Immunitas Therapeutics (@ImmunitasTx) / Twitter
WitrynaSichuan University. Jul 2015 - Jul 20161 year 1 month. No.17 People's South Road,Chengdu,610041. Responsible for computational data analysis of integrated … WitrynaCategories of Sources of Personal Data. We collect Personal Data about you from the following categories of sources: You. When you provide such information directly to us. Witryna21 lis 2024 · Immunitas Therapeutics, founded by Longwood Fund, employs a single cell genomics platform to dissect the biology of immune cells in human tumors, thereby advancing discoveries directly from the ... chillit inc archer fl